PreprintCited by 6Pancreatic function and diabetesRegulation of Appetite and ObesityNeuroscience of respiration and sleep

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia

Open access
Gaspari, Sevasti, Labouèbe, Gwenaël, Picard, Alexandre, Berney, Xavier, Sanchez-Archidona, Ana Rodriguez, Thorens, Bernard·2022·EMBO Reports

Preprint — published as 10.15252/embr.202357344 · Paper page

Abstract

The counterregulatory response to hypoglycemia (CRR), which ensures a sufficient glucose supply to the brain, is an essential survival function. It is orchestrated by incompletely characterized glucose-sensing neurons, which trigger a coordinated autonomous and hormonal response that restores normoglycemia. Here, we investigated the role of hypothalamic Tmem117 , identified in a genetic screen as a regulator of CRR. We show that Tmem117 is expressed in vasopressin magnocellular neurons of the hypothalamus. Tmem117 inactivation in these neurons increases hypoglycemia-induced vasopressin secretion leading to higher glucagon secretion, an estrus cycle phase-dependent effect in female mice. Ex vivo electrophysiological analysis, in-situ hybridization and in vivo calcium imaging reveal that Tmem117 inactivation does not affect the glucose-sensing properties of vasopressin neurons but increases ER-stress, ROS production and intracellular calcium levels accompanied by increased AVP production and secretion. Thus, Tmem117 in vasopressin neurons is a physiological regulator of glucagon secretion and highlight the role of these neurons in the coordinated response to hypoglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.10.21.513159

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. 10.1210/endo-107-6-1975 · DOI
  2. 10.1210/jcem-53-5-935 · DOI
  3. 2012, ‘The physiology and pathophysiology of the neural control of the counterregulatory response’, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 302, R215, 10.1152/ajpregu.00531.2011 · DOI · Paper page
  4. 2021, Mini-review: Glucagon responses in type 1 diabetes – a matter of complexity, Physiological Reports, 9, e15009
  5. Briski, K.P. et al. (2017) ‘Sex Differences and Role of Estradiol in Hypoglycemia-Associated Counter-Regulation’, in F. Mauvais-Jarvis (ed.) Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Cham: Springer International Publishing (Advances in Experimental Medicine and Biology), pp. 359–383. Available at: https://doi.org/10.1007/978-3-319-70178-3_17. · DOI
  6. 10.1093/bioinformatics/btg112 · DOI
  7. 2016, ‘Intrinsic Disorder in Transmembrane Proteins: Roles in Signaling and Topology Prediction’, PloS One, 11, e0158594, 10.1371/journal.pone.0158594 · DOI
  8. 10.1177/0748730419871184 · DOI
  9. 10.1159/000126185 · DOI
  10. 10.1210/en.2011-1499 · DOI · Paper page
  11. 10.1016/0196-9781(84)90109-8 · DOI
  12. Gaisano, H. , MacDonald, P. and Vranic, M . (2012) ‘Glucagon secretion and signaling in the development of diabetes’, Frontiers in Physiology, 3. Available at: https://www.frontiersin.org/articles/10.3389/fphys.2012.00349 (Accessed: 14 March 2023). · DOI
  13. 10.1016/0167-0115(92)90075-6 · DOI
  14. 2014, ‘A Parabrachial-Hypothalamic Cholecystokinin Neurocircuit Controls Counterregulatory Responses to Hypoglycemia’, Cell Metabolism, 20, 1030, 10.1016/j.cmet.2014.11.006 · DOI
  15. 10.1016/j.tcb.2018.01.002 · DOI
  16. 10.1007/s00125-005-1930-0 · DOI
  17. 10.1111/febs.13598 · DOI
  18. 2021, Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes, eLife, 10, e72919, 10.7554/eLife.72919 · DOI
  19. 2018, ‘GLUT2-Expressing Neurons as Glucose Sensors in the Brain: Electrophysiological Analysis’, Methods in Molecular Biology (Clifton, N.J, 1713, 255
  20. 2014, Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion, Cell Metabolism, 19, 527, 10.1016/j.cmet.2014.02.003 · DOI · Paper page
  21. 2021, Gq signaling in α cells is critical for maintaining euglycemia, JCI insight, 6, e152852, 10.1172/jci.insight.152852 · DOI
  22. 10.1210/en.2008-0623 · DOI
  23. 2007, ‘Brain glucose sensing, counterregulation, and energy homeostasis’, Physiology (Bethesda, Md, 22, 241
  24. 2012, Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification, JoVE (Journal of Visualized Experiments, 67, e4389
  25. 10.1073/pnas.1521160113 · DOI
  26. 2004, A new set of BXD recombinant inbred lines from advanced intercross populations in mice, BMC genetics, 5, 7, 10.1186/1471-2156-5-7 · DOI
  27. 10.1677/joe.0.1240277 · DOI
  28. 2016, A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion, Cell Reports, 17, 1795, 10.1016/j.celrep.2016.10.041 · DOI · Paper page
  29. 10.2337/db20-1121 · DOI
  30. 2022, Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion, Molecular Metabolism, 61, 101479, 10.1016/j.molmet.2022.101479 · DOI
  31. 2012, ‘Cell-type specific expression of the vasopressin gene analyzed by AAV mediated gene delivery of promoter deletion constructs into the rat SON in vivo’, PloS One, 7, p. e48860, 10.1371/journal.pone.0048860 · DOI
  32. 2011, ‘Physiologic action of glucagon on liver glucose metabolism’, Diabetes, Obesity and Metabolism, 13, 118, 10.1111/j.1463-1326.2011.01454.x · DOI · Paper page
  33. 10.1038/gt.2012.27 · DOI · Paper page
  34. 10.1038/nbt811 · DOI
  35. 10.2337/dc11-2010 · DOI · Paper page
  36. 10.1016/j.yfrne.2007.08.005 · DOI
  37. 10.1111/j.1365-2265.1985.tb00145.x · DOI · Paper page
  38. 10.1097/JES.0b013e31817be928 · DOI · Paper page
  39. 10.1210/er.2018-00226 · DOI · Paper page
  40. 10.1038/nature17183 · DOI
  41. 10.2337/db15-1514 · DOI
  42. 10.1210/en.2011-1350 · DOI
  43. 2014, Reactive oxygen species are physiological mediators of the noradrenergic signaling pathway in the mouse supraoptic nucleus, Free Radical Biology & Medicine, 71, 231, 10.1016/j.freeradbiomed.2014.03.024 · DOI
  44. 2022, ‘Lipid biosynthesis enzyme Agpat5 in AgRP-neurons is required for insulin-induced hypoglycemia sensing and glucagon secretion’, Nature Communications, 13, 5761, 10.1038/s41467-022-33484-6 · DOI
  45. 2017, ‘A novel transmembrane protein defines the endoplasmic reticulum stress-induced cell death pathway’, and Biophysical Research Communications, 486, 149, 10.1016/j.bbrc.2017.03.017 · DOI
  46. 10.1111/j.1749-6632.2010.05820.x · DOI · Paper page
  47. Thorens, B . (2022) ‘Neuronal regulation of glucagon secretion and gluconeogenesis’, Journal of Diabetes Investigation, n/a(n/a). Available at: https://doi.org/10.1111/jdi.13745. · DOI
  48. 10.1093/NAR/GKAB1061 · DOI · Paper page
  49. 10.1016/j.regpep.2004.06.010 · DOI
  50. 10.1016/j.ceca.2011.03.003 · DOI

Metadata

Authors
Gaspari, S., Labouèbe, G., Picard, A., Berney, X., Sanchez-Archidona, A. R., & Thorens, B.
Affiliations
University of Lausanne (CH)
Corresponding author
Thorens, Bernard
Venue
EMBO Reports
Publisher
openRxiv
Published
2022-10-21
Volume
24
Issue
8
Pages
e57344-e57344
ISSN
1469-221X (ISSN-L)
OpenAlex
W4380577134
Cited by
6
References
1
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1
FWCI
1.60
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • EMBO Reports (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion, cc-by-nc-nd)
  • IRIS (submittedVersion, cc-by-nc-nd)
Funders
  • National Science Foundation (310030)
  • Massachusetts Department of Agricultural Resources
  • Leona M. and Harry B. Helmsley Charitable Trust
  • European Federation of Pharmaceutical Industries and Associations
  • European Commission (777460)
  • École Polytechnique Fédérale de Lausanne
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182496, 310030)
  • H2020 European Research Council (694798)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
vasopressin neurons, hypothalamus, glucagon secretion, vasopressin release, glucose detection, endoplasmic reticulum stress, reactive oxygen species, intracellular calcium, estrous cycle, magnocellular neurons
MeSH terms
Animals, Blood Glucose, Calcium, Female, Glucagon, Glucose, Hypoglycemia, Insulin, Male, Membrane Proteins, Neurons, Vasopressins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review